Loading...

Home
ETF
NAGE

NAGE

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

AI Strategies

AI Stock Picker
Swing Trading
SwingMax Portfolio
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Follow SwingMax Portfolio
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

NAGE News

Niagen Bioscience Sponsors Inaugural NAD for Health Conference

6d agoBusinesswire

Niagen Bioscience Sponsors Inaugural NAD for Health Conference

6d agoNewsfilter

Niagen Bioscience to Host Q4 and FY 2025 Earnings Call

Feb 06 2026Businesswire

Niagen Bioscience to Host Q4 2025 Earnings Call

Feb 06 2026Newsfilter

Functional Beverage Market Set for Explosive Growth

Jan 29 2026Globenewswire

Functional Beverage Market Expected to Reach $179.26 Billion

Jan 29 2026Newsfilter

Doseology Sciences Acquires Feed That Brain for $400,000, Expanding into Performance Wellness Market

Jan 21 2026Newsfilter

Niagen Bioscience Introduces Tru Niagen® Beauty — The First NAD+ Skincare Supplement in the U.S. with Patented Niagen® (Nicotinamide Riboside)

Nov 13 2025Newsfilter

Niagen Biosciences Announces Findings from First Randomized Trial of Niagen NR for Long COVID

Nov 13 2025NASDAQ.COM

Niagen Bioscience Reveals Findings from Groundbreaking Randomized Controlled Trial on Niagen (Patented Nicotinamide Riboside, NR) Supplementation for Long COVID

Nov 13 2025Newsfilter

Niagen Bioscience (NAGE) Exceeds Expectations for Q3 Earnings and Revenue

Nov 05 2025NASDAQ.COM

Niagen Bioscience increases 2025 revenue growth forecast to 25%-30% as it broadens clinic and telehealth services.

Nov 04 2025SeekingAlpha

Niagen Bioscience Scheduled to Announce Q3 2025 Financial Results on Tuesday, November 4, 2025

Oct 21 2025Newsfilter

Explore the Details: SCHB Shows Potential for 10% Growth

Oct 10 2025NASDAQ.COM

Niagen Bioscience Launches Pharmaceutical-Grade Niagen™ IV and Injections at 50+ iCRYO Clinics and Over 900 Clinics Across the Country

Oct 01 2025Newsfilter

HC Wainwright & Co. Maintains Buy on Niagen Bioscience, Raises Price Target to $12

Aug 11 2025Benzinga